# Immunic (IMUX) — News

IMUX · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/imux/news

## Recent headlines

- [Immunic Q2 loss per share USD 0.80](https://www.ainvest.com/news/immunic-q2-loss-share-usd-0-80-2608) — AInvest Wire, Aug 11, 2026
  Immunic, Inc. reported a net loss per share of USD 0.80 for the second quarter of 2026, reflecting ongoing financial challenges in its operations [1]. The loss, which was in line with expectations based on the company’s recent guidance, underscores the continued investment in research and…
- Immunic, Inc. announces private placement of up to $240M — AInvest Wire, Jan 5, 2024
- **Important** — Immunic shares surge 54% in premarket trading on positive interim data from Phase 2 calliper trial of Vidofludimus calcium in progressive multiple sclerosis. — AInvest Wire, Oct 10, 2023
- **Important** — Immunic: Positive interim data from Vidofludimus Calcium trial — AInvest Wire, Oct 9, 2023

---

Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).